News for CHNC Stock

CBIH Announces the Completion of the “Phase of Research and Discovery" for Its Phytotherapy Cancer Scientific Project CHNC Announces to Its Allies the Rebranding and Name Change to Cannabis Bioscience International Holdings Cannabis Bioscience International Holdings Announces the Appointment of Former Dallas Cowboy David Irving as Spokesperson of Our Company CHNC Completes Review of Its First Three Fiscal Quarters CHNC Announces Return of Half a Billion Shares CHNC Announces Completion of Audited Financial Statements CHNC - Alpha Research Institute Update CHNC Continues to Position Itself as Colombia’s Quintessential Medical Cannabis Educator CHNC Announces New Relationship with a Houston, Texas-based Professional PCAOB Accounting Firm CHNC Seeks To Continue To Bring Medical Cannabis Education To The Middle East With New Brand Ambassador CHNC Ventures Into Latin American Country for Extension of Its Clinical Research Facilities CHNC Announces a New Member of Its Board of Directors CHNC Endeavors in Artificial Intelligence Systems for Its Educational Content CHNC to Seek Up to $3 Million Funding for Expansion of Existing Product Lines and Development of New Cannabis-Derived Therapeutics CHNC's Shareholders Rewarded with Astonishing Investment Return of Over 2500% During this Last Year CHNC Expands Distribution of Its Educational Training Programs Through Leading Online Digital Distributors CHNC Announces Name Change to Cannabis Bioscience International Holdings, Inc. CHNC: Intensity, Determination and a Magical Unwavering Direction Transports CHNC to Become the Macondo of Medical Cannabis Research CHNC Saga, Metamorphosis, and Transformation